文献速递营养与食品安全传染病防控与疫情报告

商业疫苗通过减少火鸡肠道定植实现对婴儿沙门菌和哈达尔沙门菌的交叉保护

Commercial vaccine provides cross-protection by reducing colonization of Salmonella enterica serovars Infantis and Hadar in turkeys.
PubMed 文献 · Vaccine · 2024-01-13

本研究评估商业减毒鼠伤寒沙门菌(B群)疫苗对火鸡感染C群婴儿沙门菌和哈达尔沙门菌的交叉保护。疫苗显著减少肠道组织(盲肠、盲肠扁桃体、泄殖腔)定植及脾脏系统播散,并阻止婴儿沙门菌向骨髓播散。

要点

  • 减毒鼠伤寒沙门菌疫苗接种显著减少婴儿沙门菌和哈达尔沙门菌在火鸡肠道组织的定植。
  • 疫苗显著限制两种C群沙门菌向脾脏的系统性播散。
  • 未接种火鸡中婴儿沙门菌可播散至骨髓,接种后播散被阻止。

核心结论

  • 用B群鼠伤寒沙门菌疫苗接种火鸡可限制C群婴儿沙门菌和哈达尔沙门菌的肠道定植与系统播散。

研究设计与样本

  • 研究评估商业减毒鼠伤寒沙门菌(B群)疫苗对火鸡婴儿沙门菌(C1群)和哈达尔沙门菌(C2群)的交叉保护。

主要发现

  • 疫苗显著减少婴儿沙门菌和哈达尔沙门菌对肠道组织(盲肠、盲肠扁桃体、泄殖腔)的定植。
  • 疫苗显著限制两种沙门菌向脾脏的系统性播散。
  • 未接种火鸡中婴儿沙门菌可播散至骨髓,接种后未发生骨髓播散。
  • 婴儿沙门菌攻击株携带pESI巨质粒,该质粒上的毒力机制可能支持系统生态位(如髓样组织)的播散和/或定植。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human foodborne outbreaks with antibiotic-resistant Salmonella enterica associated with contaminated poultry products have recently involved serogroup C serovars Infantis and Hadar. The current study evaluated a commercially available Salmonella vaccine for cross-protection against Infantis and Hadar serovars in turkeys. The live, attenuated S. Typhimurium (serogroup B) vaccine significantly reduced colonization of intestinal tissues (cecum, cecal tonsils, and cloaca) by serovars Infantis (C1) and Hadar (C2) and significantly limited systemic dissemination to the spleen. S. Infantis, but not S. Hadar, disseminated to bone marrow in non-vaccinated turkeys, but vaccination prevented S. Infantis dissemination to the bone marrow. The S. Infantis challenge strain contained the pESI megaplasmid, and virulence mechanism(s) residing on this plasmid may support dissemination and/or colonization of systemic niches such as myeloid tissue. Collectively, the data indicate that vaccinating turkeys with the serogroup B S. Typhimurium vaccine limited intestinal colonization and systemic dissemination by serogroup C serovars Infantis and Hadar.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bearson SMD, Monson MS, Bearson BL, et al. Commercial vaccine provides cross-protection by reducing colonization of Salmonella enterica serovars Infantis and Hadar in turkeys. Vaccine. 2024. PMID: 38220490. doi:10.1016/j.vaccine.2023.12.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。